SEC Form 4 · accession 0001127602-16-067133
TOMPKINS FINANCIAL CORP · TMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M McKenna
Officer — EVP, Tompkins Bank of Castile
Period of report
Nov 11, 2016
Accepted (ET)
Nov 15, 2016 · 1:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005817
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2016 | M | 1,760 | $41.71 | A | 9,758 | D | |
| Common StockF1 | Nov 11, 2016 | F | 1,223 | $78.40 | D | 8,535 | D | |
| Common Stock | Nov 11, 2016 | M | 884 | $37.00 | A | 9,419 | D | |
| Common StockF1 | Nov 11, 2016 | F | 580 | $78.40 | D | 8,839 | D | |
| Common Stock | Nov 11, 2016 | M | 372 | $40.60 | A | 9,211 | D | |
| Common StockF1 | Nov 11, 2016 | F | 255 | $78.40 | D | 8,956 | D | |
| Common Stock | holding | — | — | — | 803 | I | by 401(K) ESOP | |
| Common Stock | holding | — | — | — | 101 | I | by 401(K) ISOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights (SAR)F2 | $41.71 | Nov 11, 2016 | M | 1,760 | D | — | Sep 17, 2019 | Common Stock | 1,760 | 0 | D |
| Stock Appreciation Rights (SAR)F2 | $37.00 | Nov 11, 2016 | M | 884 | D | — | Aug 19, 2021 | Common Stock | 884 | 416 | D |
| Stock Appreciation Rights (SAR)F2 | $40.60 | Nov 11, 2016 | M | 372 | D | — | May 3, 2023 | Common Stock | 372 | 723 | D |
Explanation of responses
- F1Deemed disposition of shares to Issuer to satisfy option cost and taxes.
- F2Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.